Related Experiment Video
Updated: Jan 27, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
MEST induces Twist-1-mediated EMT through STAT3 activation in breast cancers
Min Soo Kim1, Hyun Sook Lee2,3, Yun Jae Kim2,3
1Laboratory of Molecular Disease and Cell Regulation, Department of Biochemistry, School of Medicine, Gachon University, Incheon, 406-840, Korea.
Abstract:
The loss of imprinting of MEST has been linked to certain types of cancer by promoter switching. However, MEST-mediated regulation of tumorigenicity and metastasis are yet to be understood. Herein, we reported that MEST is a key regulator of IL-6/JAK/STAT3/Twist-1 signal pathway-mediated tumor metastasis. Enhanced MEST expression is significantly associated with pathogenesis of breast cancer patients. Also, MEST induces metastatic potential of breast cancer through induction of the EMT-TFs-mediated EMT program. Moreover, MEST leads to Twist-1 induction by STAT3 activation and subsequently enables the induction of activation of the EMT program via the induction of STAT3 nuclear translocation. Furthermore, the c-terminal region of MEST was essential for STAT3 activation via the induction of JAK2/STAT3 complex formation. Finally, MEST is required for metastasis in an experimental metastasis model. These observations suggest that MEST is a promising target for intervention to prevent tumor metastasis.
Insights
MEST protein promotes breast cancer metastasis by activating the IL-6/JAK/STAT3/Twist-1 pathway and inducing epithelial-mesenchymal transition (EMT). Targeting MEST could prevent tumor spread.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Loss of imprinting of MEST is linked to cancer via promoter switching.
- MEST's role in tumor growth and metastasis requires further elucidation.
Purpose of the Study:
- To investigate MEST's function in breast cancer metastasis.
- To identify the molecular mechanisms underlying MEST-driven metastasis.
Main Methods:
- Analysis of MEST expression in breast cancer patients.
- Investigating MEST's effect on epithelial-mesenchymal transition (EMT).
- Studying the IL-6/JAK/STAT3/Twist-1 signaling pathway and MEST's role in metastasis using experimental models.
Main Results:
- Elevated MEST expression correlates with breast cancer pathogenesis.
- MEST enhances breast cancer cell metastatic potential by inducing EMT via the IL-6/JAK/STAT3/Twist-1 pathway.
- MEST activates STAT3, promoting Twist-1 expression and EMT.
- The C-terminal region of MEST is crucial for JAK2/STAT3 complex formation and STAT3 activation.
- MEST is essential for metastasis in experimental models.
Conclusions:
- MEST is a key regulator of breast cancer metastasis through the IL-6/JAK/STAT3/Twist-1 pathway.
- MEST drives EMT and promotes tumor spread.
- MEST represents a potential therapeutic target for preventing breast cancer metastasis.
Related Concept Videos
Angle of Twist: Problem Solving
Angle of Twist - Elastic Range
Mechanisms of Retrovirus-induced Cancers
Receptor-mediated Endocytosis
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

